<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="9a41736c-fe6b-4dba-80cd-d8e2b6c3d38c"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Neurology (multiple sclerosis) Consultation — Jacqueline du Pré</title>
  <effectiveTime value="20260323120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="3f801b84-71bf-47d3-9d9a-5d9c731b1b00"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="a616df5f-7768-413c-a23b-75c6fd159a8d" extension="HR-ML039-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-39-7062"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Jacqueline</given><given>Mary</given><family>du Pré</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19980126"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260323120000-0500"/>
    <assignedAuthor><id root="898df929-8c8a-4eff-aa3e-640338ff7ad5"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rafael</given><family>Lindgren-Achebe</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260323120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="898df929-8c8a-4eff-aa3e-640338ff7ad5"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rafael</given><family>Lindgren-Achebe</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="bddfeb7f-75c1-4ea4-99dc-d15e87814ec3"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="898df929-8c8a-4eff-aa3e-640338ff7ad5"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rafael</given><family>Lindgren-Achebe</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="5ea2e13a-8643-4f62-bc36-697fa6c8c50b"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Diagnosis of relapsing-remitting multiple sclerosis: neurology consultation, treatment of the relapse, choice of high-efficacy disease-modifying therapy, and vaccinations before B-cell therapy</originalText></code>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="898df929-8c8a-4eff-aa3e-640338ff7ad5"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rafael</given><family>Lindgren-Achebe</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>Suspected demyelinating disease in a 28-year-old professional cellist with three weeks of numbness, loss of position sense and clumsiness in the fingers of both hands, worse on the left, Lhermitte&apos;s sign and fatigue, after a similar month of finger tingling 18 months ago. MRI of the brain and cervical and thoracic spine with gadolinium is booked this week. Please see her within two weeks to review the MRI with her, confirm or exclude multiple sclerosis, and plan treatment. [S]</paragraph><paragraph>Urgency: Urgent, within two weeks. [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>Does she have multiple sclerosis by current criteria, and what further tests are needed, including tests for mimics?</item><item>Should the current episode be treated, and how?</item><item>Which disease-modifying therapy do you recommend, and why, given her age, activity, travel and wish for children in future?</item><item>What screening and vaccinations are needed before treatment, and what monitoring should primary care share?</item><item>What can be done for her hand function and fatigue so that she can keep playing and teaching?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. du Pré, 28, is seen at the request of Dr. Thackeray-Osei two weeks after she presented with numbness and clumsiness of the fingers of both hands, Lhermitte&apos;s sign and fatigue. She has since had MRI of the brain and spine with gadolinium and a lumbar puncture. Her fingers are no better: she can practice only a few minutes at a time and has cancelled two more concerts. She recalls a month of finger tingling about 18 months ago that settled without treatment; she has had no visual loss, double vision, imbalance or bladder symptoms. She travels for concerts and teaches. She is not planning a pregnancy this year but would like children in future. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Jacqueline Mary du Pré was born in Oxford, England, on 26 January 1945. Her mother was a pianist who had studied at the Royal Academy of Music, and her father an accountant. [D]</item><item>She began the cello as a small child, studied with William Pleeth at the Guildhall School of Music from the mid-1950s, won the Guilhermina Suggia Award at 11 in 1956 and the Queen&apos;s Prize at 15, attended a Pablo Casals masterclass in Zermatt in 1960, and made her formal debut at Wigmore Hall in London in March 1961, at 16. [D]</item><item>In 1965, at 20, she recorded Elgar&apos;s Cello Concerto with the London Symphony Orchestra under Sir John Barbirolli; she played chiefly on the Davidov Stradivarius of 1712. [D]</item><item>She converted to Judaism and married her husband, a pianist and conductor, in Jerusalem in June 1967. [D]</item><item>In 1971 her playing declined as she began to lose sensitivity in her fingers and other parts of her body; she returned to England exhausted, took a sabbatical from 1971 to 1972 and performed only rarely. When she resumed in 1972 the numbness in her fingers worsened, with fatigue. [D]</item><item>Two physicians writing about her illness note episodes of blurred vision in her teens, which they read as possibly an early sign of multiple sclerosis. [R]</item><item>Her last public concerts were in February 1973, in London, where she played the Elgar Concerto, and in New York. [D]</item></list><paragraph>5 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="7c188938-b388-44b1-b2b2-824327e62ec7"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="54d3f8c0-eaf6-4706-b18f-93c27eec4d31"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-3"><td>Cholecalciferol (vitamin D3) 4000 unit (100 microgram) oral capsule, one capsule by mouth daily</td><td>One capsule daily</td><td>Oral route</td><td>2026-03-23</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="f97c6ecd-6428-4534-bc77-f92fe068dc05"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1092380" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.1 MG Oral Capsule"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e7a4c2dd-0c18-4e28-a576-619cd4459a6f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Numbness, tingling and loss of position sense in the fingers of both hands for three weeks, worse on the left, with clumsiness that makes her lose her place on the fingerboard, an electric feeling down the spine on bending the neck (Lhermitte&apos;s sign), and fatigue; a similar month of tingling in the fingers 18 months ago settled on its own. A lesion of the cervical spinal cord must be found: MRI of the brain and spine with contrast booked this week</td><td>resolved</td><td>confirmed</td>
    <td>R20.2</td><td>S — Synthetic presenting problem anchored to her documented loss of sensation in her fingers and fatigue. Superseded by the diagnosis at the second visit.</td>
  </tr>
  <tr ID="problem-2">
    <td>Relapsing-remitting multiple sclerosis, active: a current relapse (partial cervical myelitis at C3 to C4 with sensory loss and clumsiness of the hands) after an earlier sensory episode; dissemination in space and time on MRI, with an enhancing cord lesion and an enhancing brain lesion; CSF-specific oligoclonal bands; aquaporin-4 antibody negative; meets the 2017 McDonald criteria and the 2024 revision; synthetic modern detail linked to her documented diagnosis</td><td>active</td><td>confirmed</td>
    <td>G35.A</td><td>S — Synthetic course, imaging and laboratory detail; linked to her documented diagnosis in October 1973.</td>
  </tr>
  <tr ID="problem-3">
    <td>Vitamin D deficiency: 25-hydroxyvitamin D 16 ng/mL; replacement to correct the deficiency, not as a treatment for multiple sclerosis</td><td>active</td><td>confirmed</td>
    <td>E55.9</td><td>S — Synthetic finding.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="e3d10112-7347-4227-89bd-2661888f97b9"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260309"/><high value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="cbaacce4-1d4f-4845-a8f5-cedcbac25520"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/><high value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="R20.2" codeSystem="2.16.840.1.113883.6.90" displayName="Paresthesia of skin"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b2cdd90a-ff33-41aa-aa91-b570324c95ed"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="bca9c88d-8952-4418-9f6a-49aef781539c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="G35.A" codeSystem="2.16.840.1.113883.6.90" displayName="Relapsing-remitting multiple sclerosis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="11c98afd-5c8f-4696-8118-87b7f403eb61"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="ad41a5f8-becb-4b34-8002-3976438707b0"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-03-23; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>Cranial nerves</td><td>Normal; no nystagmus; normal acuity, fields and fundi</td></tr><tr><td>Motor</td><td>Strength 5 out of 5 except left finger abduction 4+; tone normal; reflexes brisk in the arms, normal in the legs; plantar responses flexor</td></tr><tr><td>Sensory</td><td>Reduced vibration and joint position sense in the fingers of both hands, worse on the left, with mild pseudoathetosis of the left fingers with the eyes closed; Lhermitte&apos;s sign present</td></tr><tr><td>Coordination and gait</td><td>Nine-hole peg test 24.5 seconds right, 31.0 seconds left; finger-nose normal; gait, tandem and Romberg normal. EDSS 2.0</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-17"><td>2026-03-23</td><td>25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma</td><td>16</td><td>ng/mL</td><td>Below 20 ng/mL deficient; 20 to 29 insufficient</td><td>Low</td><td>S</td></tr>
  <tr ID="result-18"><td>2026-03-23</td><td>IgG [Mass/volume] in Serum or Plasma</td><td>1080</td><td>mg/dL</td><td>700-1600 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-19"><td>2026-03-23</td><td>IgM [Mass/volume] in Serum or Plasma</td><td>124</td><td>mg/dL</td><td>40-230 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-20"><td>2026-03-23</td><td>Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]</td><td>7</td><td>{score}</td><td></td><td></td><td>S</td></tr>
  <tr ID="result-21"><td>2026-03-23</td><td>Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]</td><td>6</td><td>{score}</td><td></td><td></td><td>S</td></tr>
  <tr ID="result-22"><td>2026-03-23</td><td>9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]</td><td>24.5</td><td>s</td><td></td><td></td><td>S</td></tr>
  <tr ID="result-23"><td>2026-03-23</td><td>9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]</td><td>31</td><td>s</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="faef8e84-cb76-4798-b208-cbe08004f398"/>
      <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="bdac76d8-c5cc-40dd-b9e9-8a7ba0841ad5"/>
          <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-17"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="16" unit="ng/mL"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>Below 20 ng/mL deficient; 20 to 29 insufficient</text>
              <value xsi:type="IVL_PQ"><low value="20" unit="ng/mL"/><high value="100" unit="ng/mL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="b73b2eb8-5638-4f63-aaf0-842a8421368b"/>
      <code code="2465-3" codeSystem="2.16.840.1.113883.6.1" displayName="IgG [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="360994a5-1ea7-430f-95da-b64edb6de5e4"/>
          <code code="2465-3" codeSystem="2.16.840.1.113883.6.1" displayName="IgG [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-18"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="1080" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>700-1600 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="700" unit="mg/dL"/><high value="1600" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="91530cfb-bf35-4f59-8f57-637318802077"/>
      <code code="2472-9" codeSystem="2.16.840.1.113883.6.1" displayName="IgM [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="dc06e99c-122f-43a8-9c32-7a90a43975df"/>
          <code code="2472-9" codeSystem="2.16.840.1.113883.6.1" displayName="IgM [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-19"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="124" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>40-230 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="40" unit="mg/dL"/><high value="230" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="d6ff3097-d797-4a05-b84e-4b04e294ccf0"/>
      <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="0d42c702-fba2-48bf-8b15-46e34335e9ae"/>
          <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
          <text><reference value="#result-20"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="7" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="3be8dd24-4916-47ae-b518-d52ef41d2123"/>
      <code code="70274-6" codeSystem="2.16.840.1.113883.6.1" displayName="Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="0bdeec0a-7ecf-4240-84c2-c69504922c74"/>
          <code code="70274-6" codeSystem="2.16.840.1.113883.6.1" displayName="Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]"/>
          <text><reference value="#result-21"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="6" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="84b609cc-0696-46d9-8b83-caf7fb304ab2"/>
      <code code="83157-8" codeSystem="2.16.840.1.113883.6.1" displayName="9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="4498d24c-83a6-4e1d-958e-58bb8eb3cc14"/>
          <code code="83157-8" codeSystem="2.16.840.1.113883.6.1" displayName="9-Hole Pegboard Dexterity Test Time Hand - right [NIH Toolbox]"/>
          <text><reference value="#result-22"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="24.5" unit="s"/>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="370c1fae-2a97-4ea9-a1ab-1b10764df048"/>
      <code code="83156-0" codeSystem="2.16.840.1.113883.6.1" displayName="9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="542959a5-672c-484d-a14a-96c3429bb603"/>
          <code code="83156-0" codeSystem="2.16.840.1.113883.6.1" displayName="9-Hole Pegboard Dexterity Test Time Hand - left [NIH Toolbox]"/>
          <text><reference value="#result-23"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="31" unit="s"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>Relapsing-remitting multiple sclerosis, active (G35.A). Multiple sclerosis by the 2017 McDonald criteria: a current attack of partial cervical myelitis, with dissemination in space in four regions and dissemination in time shown by enhancing and non-enhancing lesions on the same scan; CSF-specific oligoclonal bands add certainty. The 2024 revision is also met, and central veins support the diagnosis. The earlier episode of finger tingling was probably a first attack. Mimics were considered and excluded: normal B12 and thyroid function, negative aquaporin-4 antibody (a cell-based assay is needed for any myelitis), negative HIV and syphilis serology. MOG antibody testing is not indicated: there is no optic neuritis, long cord lesion or ADEM-like illness, and the lesions are typical of MS. With a disabling relapse, an enhancing cord lesion and multiple lesions at 28, her disease is active, and early high-efficacy treatment gives the best long-term outcome. [S]</item><item>Vitamin D deficiency (E55.9). Correct the deficiency; vitamin D is not a treatment for MS. [S]</item></list><paragraph>Data reviewed: Dr. Thackeray-Osei&apos;s intake note and results. MRI of the brain with gadolinium: eleven ovoid T2 lesions, eight periventricular (several perpendicular to the ventricles), two juxtacortical and one in the right middle cerebellar peduncle; one periventricular lesion enhances; central veins in most lesions. MRI of the cervical and thoracic spine: short dorsal lesion at C3 to C4 with patchy enhancement, non-enhancing lesion at T7, no swelling. Lumbar puncture: white cells 6, protein 42 mg/dL, six CSF-specific oligoclonal bands, IgG index 0.86. Serum aquaporin-4 IgG (cell-based) negative; HIV and syphilis negative; JCV antibody positive, index 1.4. Vitamin B12 468 pg/mL and TSH 1.6 mIU/L at the first visit. Drawn with the lumbar puncture: hepatitis B surface antigen and core antibody negative, surface antibody negative; varicella IgG positive. Today: 25-hydroxyvitamin D 16 ng/mL; IgG 1080 and IgM 124 mg/dL; urine pregnancy test negative. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>Treat the relapse, which limits her hand function and her work: methylprednisolone 1 g intravenously daily for 3 days after a negative urine dipstick (oral methylprednisolone 500 mg daily for 5 days is an equivalent alternative). [S]</item><item>Early high-efficacy disease-modifying therapy with ocrelizumab: 300 mg intravenously on day 1 and day 15, then 600 mg every six months, with methylprednisolone 100 mg, an antihistamine and acetaminophen before each infusion. Natalizumab is not advised because her JCV antibody is positive, which raises the risk of PML with longer use; ofatumumab is an equally effective option that she declined in favor of twice-yearly infusions. [S]</item><item>Before the first infusion: hepatitis B screening (done; not immune), immunoglobulins, varicella and measles immunity, and a pregnancy test; inactivated vaccines at least two weeks before (PCV20, recombinant zoster and hepatitis B started today), and no live vaccines once treatment starts. Check hepatitis B surface antibody one to two months after the series. [S]</item><item>Re-baseline MRI of the brain three to six months after starting, then yearly; blood count and immunoglobulins before each dose; teach her that infections, especially urinary infections, are more common and can cause a pseudo-relapse that does not need steroids. [S]</item><item>Occupational therapy for hand function and energy management, and a graded return to practice; aerobic exercise and pacing for fatigue after excluding other causes. [S]</item><item>Cholecalciferol 4000 units daily for the deficiency, with a level in three months. [S]</item><item>Pregnancy: contraception for now; when she is ready, a preconception visit, with conception planned a few months after an ocrelizumab dose. [S]</item><item>Primary care to share the monitoring: blood tests before infusions, vaccinations, infection review, mood and fatigue. [S]</item><item>Discussed with Dr. Thackeray-Osei the same day. The MRI and spinal fluid results were shown and explained to Ms. du Pré in plain words, with the good outlook for hand recovery after a first cord relapse and the evidence that early high-efficacy treatment protects long-term function. She chose ocrelizumab. She decides who else receives this note. [S]</item><item>Follow-up: Methylprednisolone from tomorrow; first ocrelizumab infusion in three weeks; neurology review at three months with the re-baseline MRI, then every six months; MS specialist nurse available between visits. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
